CVRx (CVRX) Research & Development (2020 - 2026)
CVRx's (CVRX) quarterly Research & Development came in at $3.1 million in Q1 2026, up 22.53% year-on-year from $2.5 million in Q1 2025, and up 2.8% quarter-over-quarter from $3.0 million in Q4 2025.
CVRx (CVRX) Research & Development (2020 - 2026) Analysis & Trends
CVRx's Research & Development history runs 7 years deep, the most recent figure standing at $3.1 million for Q1 2026.
- On a quarterly basis, Research & Development rose 22.53% year-over-year to $3.1 million in Q1 2026; TTM through Mar 2026 was $11.7 million, a 10.46% increase from a year earlier, with the FY2025 full-year figure at $11.1 million, changed 0.01% from the prior year.
- Research & Development improved to $3.1 million in Q1 2026 per CVRX's latest filing, from $3.0 million in the prior quarter.
- Across five years, Research & Development topped out at $3.4 million in Q1 2023 and bottomed at $2.2 million in Q4 2023.
- The 5-year median for Research & Development is $2.8 million (2024), against an average of $2.8 million.
- Across the five-year window, Research & Development jumped 69.5% in 2022 and fell 26.43% in 2023, its largest moves.
- Year by year, Research & Development stood at $3.0 million in 2022, then declined by 26.43% to $2.2 million in 2023, then gained by 25.17% to $2.8 million in 2024, then gained by 6.95% to $3.0 million in 2025, then grew by 2.8% to $3.1 million in 2026.
- Per Business Quant, the three latest CVRX Research & Development figures stand at $3.1 million (Q1 2026), $3.0 million (Q4 2025), and $3.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn | 3.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.08 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 3.15 Mn |
| Jun 30, 2025 | 2.47 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Dec 31, 2024 | 2.81 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Mar 31, 2024 | 3.06 Mn |
| Dec 31, 2023 | 2.24 Mn |
| Sep 30, 2023 | 2.70 Mn |
| Jun 30, 2023 | 3.28 Mn |
| Mar 31, 2023 | 3.42 Mn |
| Dec 31, 2022 | 3.05 Mn |
| Sep 30, 2022 | 2.29 Mn |
| Jun 30, 2022 | 2.36 Mn |
| Mar 31, 2022 | 2.26 Mn |
| Dec 31, 2021 | 1.80 Mn |
| Sep 30, 2021 | 1.70 Mn |
| Jun 30, 2021 | 2.26 Mn |